These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 35454096)

  • 1. α-Synuclein at the Presynaptic Axon Terminal as a Double-Edged Sword.
    Tan LY; Tang KH; Lim LYY; Ong JX; Park H; Jung S
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein Mutation Inhibits Endocytosis at Mammalian Central Nerve Terminals.
    Xu J; Wu XS; Sheng J; Zhang Z; Yue HY; Sun L; Sgobio C; Lin X; Peng S; Jin Y; Gan L; Cai H; Wu LG
    J Neurosci; 2016 Apr; 36(16):4408-14. PubMed ID: 27098685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
    Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
    Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology.
    Longhena F; Faustini G; Spillantini MG; Bellucci A
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains.
    Longhena F; Faustini G; Varanita T; Zaltieri M; Porrini V; Tessari I; Poliani PL; Missale C; Borroni B; Padovani A; Bubacco L; Pizzi M; Spano P; Bellucci A
    Brain Pathol; 2018 Nov; 28(6):875-888. PubMed ID: 29330884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
    Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
    Bougea A; Stefanis L; Emmanouilidou E; Vekrelis K; Kapaki E
    J Neural Transm (Vienna); 2020 Mar; 127(3):311-322. PubMed ID: 31912280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.
    Lewis KA; Yaeger A; DeMartino GN; Thomas PJ
    J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an Alternatively Spliced α-Synuclein Isoform That Generates a 41-Amino Acid N-Terminal Truncated Peptide, 41-syn: Role in Dopamine Homeostasis.
    Vinnakota RL; Yedlapudi D; Manda KM; Bhamidipati K; Bommakanti KT; RangaLakshmi GS; Kalivendi SV
    ACS Chem Neurosci; 2018 Dec; 9(12):2948-2958. PubMed ID: 29996045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans.
    Huang X; Wang C; Chen L; Zhang T; Leung KL; Wong G
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166203. PubMed ID: 34146705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.
    Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA
    Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease.
    Spinelli KJ; Taylor JK; Osterberg VR; Churchill MJ; Pollock E; Moore C; Meshul CK; Unni VK
    J Neurosci; 2014 Feb; 34(6):2037-50. PubMed ID: 24501346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein.
    Vicario M; Cieri D; Vallese F; Catoni C; Barazzuol L; Berto P; Grinzato A; Barbieri L; Brini M; Calì T
    Cell Death Dis; 2019 Nov; 10(11):857. PubMed ID: 31719530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of α-Synuclein in the mouse retina is confined to inhibitory presynaptic elements.
    Yang Q; Lin X; Xiao J; Zhong W; Wang F; Tan H; Rao B; Qu J; Zhang J
    J Comp Neurol; 2023 Jul; 531(10):1057-1079. PubMed ID: 37002599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.
    Kramer ML; Schulz-Schaeffer WJ
    J Neurosci; 2007 Feb; 27(6):1405-10. PubMed ID: 17287515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
    Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
    Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Protein Complementation Demonstrates Presynaptic α-Synuclein Oligomerization and Age-Dependent Accumulation of 8-16-mer Oligomer Species.
    Kiechle M; von Einem B; Höfs L; Voehringer P; Grozdanov V; Markx D; Parlato R; Wiesner D; Mayer B; Sakk O; Baumann B; Lukassen S; Liss B; Ekici AB; Ludolph AC; Walther P; Ferger B; McLean PJ; Falkenburger BH; Weishaupt JH; Danzer KM
    Cell Rep; 2019 Nov; 29(9):2862-2874.e9. PubMed ID: 31775051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
    Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG
    Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.